Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 6 (RPL21P6)

Target
RPL21P6
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L21 pseudogene 6 (RPL21P6) is a processed pseudogene, meaning it is a copy of the ribosomal protein L21 gene that has accumulated mutations rendering it non-functional for protein coding[4][8][5]. RPL21P6 is one of over a hundred pseudogenes derived from the parent RPL21 ribosomal protein gene in the human genome[5][6]. While most pseudogenes, including RPL21P6, do not produce functional proteins, some can have regulatory roles at the transcript level, such as acting as RNA molecules that modulate expression of the parent ribosomal protein gene through mechanisms like RNA interference or by serving as "sponges" for microRNAs[2]. There is no evidence that RPL21P6 encodes an active receptor, enzyme, or any other druggable protein, nor is it directly associated with disease pathology or used as a drug target or biomarker[4][8][11]. The parent gene, *RPL21* (60S ribosomal protein L21), encodes a component of the large ribosomal 60S subunit in the cytoplasm, but RPL21P6 itself is a non-coding pseudogene[7][10][8].

Other names
RPL21_47_1368RPL21P6
02

Biological functions

Other (Serves as a non-coding, non-functional DNA sequence; may regulate parent ribosomal gene by RNA interference or as a competitive endogenous RNA)
03

Disease associations

Other (No direct disease roles; however, RP pseudogenes in general can influence ribosomal protein gene regulation in stress and diseases such as depression)

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 6 (RPL21P6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 6 (RPL21P6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call